The Carvedilol Hibernation Reversible Ischaemia Trial, Marker of Success (CHRISTMAS) study: Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure
- 15 February 2000
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 72 (3), 265-274
- https://doi.org/10.1016/s0167-5273(99)00198-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart FailureCirculation, 1996
- Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Predicting survival after coronary revascularization for ischemic cardiomyopathyThe Annals of Thoracic Surgery, 1995
- Results of Revascularization in Patients With Severe Left Ventricular DysfunctionCirculation, 1995
- Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart DiseaseCirculation, 1995
- Coronary artery bypass in patients with severely depressed ventricular functionThe Annals of Thoracic Surgery, 1993
- Acute hemodynamic effects of carvedilol versus metoprolol in idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1991
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975